PG (prostaglandin) E 2 plays an important role in the modulation of the immune response and the inflammatory process. In the present study, we describe a PGE 2 positive feedback for COX (cyclo-oxygenase)-2 and mPGES-1 [microsomal PGES (PGE synthase)-1] expression in the macrophage cell line RAW 264.7. Our results show that PGE 2 induces COX-2 and mPGES-1 expression, an effect mimicked by dbcAMP (dibutyryl-cAMP) or forskolin. Furthermore, the cAMP signalling pathway cooperates with LPS (lipopolysaccharide) in the induction of COX-2 and mPGES-1 transcriptional activation. Analysis of the involvement of PGE receptors [EPs (E-prostanoids)] showed that incubation with EP2 agonists up-regulated both COX2 and mPGES-1 mRNA levels. Moreover, EP2 receptor overexpression enhanced the transcriptional activation of COX2 and mPGES-1 promoters. This induction was repressed by the PKA (protein kinase A) inhibitor H89. Activation of the PGE 2 /EP2/PKA signalling pathway induced the phosphorylation of CREB [CRE (cAMP-response element)-binding protein] in macrophages and stimulated the specific binding of this transcription factor to COX2 and mPGES-1 promoters. Deletion or mutation of potential CRE sites in both promoters diminished their transcriptional activity. In summary, the results of the present study demonstrate that activation of PKA/CREB signalling through the EP2 receptor by PGE 2 plays a key role in the expression of COX-2 and mPGES-1 in activated macrophages.
INTRODUCTION
PGs (prostaglandins) and TXs (thromboxanes) are important lipid mediators involved in physiological and pathological processes. These agents are generated from the conversion of AA (arachidonic acid) into the intermediate mediator PGH 2 by two different COXs (cyclo-oxygenases), COX-1 and COX-2 (reviewed in [1, 2] ). These enzymes are the target of NSAIDs (non-steroidal anti-inflammatory drugs) [3] . COX-1 has been defined as a constitutive enzyme that generates PGs within physiological homoeostasis. In contrast, COX-2 is an inducible enzyme responsible for PG production in different pathological processes involving inflammation, such as infectious diseases, cancer, arthritis and atherosclerosis [4] [5] [6] [7] . PGH 2 is the substrate of different PG and TX synthases that, in turn, generate a range of prostanoids with potent and diverse biological effects, such as PGD 2 , PGE 2 , PGF 2α , PGI 2 and TXA 2 . Three types of PGESs (PGE synthases) participating in the synthesis of PGE 2 have been described: one cPGES (cytosolic PGES) and two membraneassociated PGESs, mPGES (microsomal PGES)-1 and -2 [3, 8] . mPGES-1, which belongs to the MAPEG (membrane-associated proteins involved in eicosanoid and glutathione metabolism) superfamily, is inducible by similar stimuli that induce COX-2, its induction also being suppressed by glucocorticoids. Moreover, mPGES-1 appears to be functionally coupled with COX-2 and its induction is usually co-ordinated with COX-2 [9] . In macrophages, large amounts of PGE 2 are generated during the inflammatory process, due to up-regulation of both COX-2 and mPGES-1 enzymes. Co-ordinated induction of the expression of COX-2 and mPGES-1 by pro-inflammatory stimuli, such as LPS (lipopolysaccharide), IL (interleukin)-1β or TNFα (tumour necrosis factor α), has been reported in several cell types [10] [11] [12] [13] .
Prostanoids released into the extracellular medium exert their biological effects in an autocrine or paracrine fashion upon interaction with prostanoid receptors present in target cells. PGE 2 signals through four G-protein-coupled receptors named EP (Eprostanoid) 1, EP2, EP3 and EP4 (reviewed in [14] [15] [16] [17] ). EP receptors are linked to different transduction pathways that may even give rise to opposite effects, i.e. activation or inhibition, on cellular responses. Thus EP3 induces the inhibition of adenylate cyclase, leading to a decrease in cAMP, whereas EP2 and EP4 receptors activate this enzyme. On the other hand, EP1 is coupled to G αq and its activation results in an increase in intracellular calcium.
cAMP is thought to be the main intracellular second messenger of PGE 2 signalling in macrophages, playing a crucial role in the modulation of the functional activity of macrophages and monocytes. In fact, PGE 2 -dependent elevation of intracellular cAMP in LPS-stimulated macrophages results in a decreased synthesis of pro-inflammatory cytokines, including TNFα [18, 19] and IL-1β [20] , and in an increased production of the inflammatory cytokine IL-10 [21] . On the other hand, stimuli known to elevate intracellular cAMP levels, such as PGE 2 , may positively modulate COX-2 expression [22, 23] .
We have previously reported an essential role of NF-κB (nuclear factor κB) and EGR-1 (early growth-response gene product 1) as key factors involved in co-ordinated up-regulation of COX-2 and mPGES-1 expression in macrophages in response to LPS, leading to increased PGE 2 production [13] . In the present study, we explore the importance of cAMP signalling in the regulation of COX-2 and mPGES-1 in LPS-stimulated macrophages, analysing the role of PGE 2 -dependent signalling. Our results show that PGE 2 induces transcriptional activation of both COX-2 and mPGES-1 via mechanisms involving EP2 receptor activation and the cAMP/PKA (protein kinase A)/CREB [CRE (cAMP-response element)-binding protein] signalling pathway. This positivefeedback regulation of the PGE 2 -synthesizing enzymes COX-2 and mPGES-1 in macrophages constitutes an amplification signalling that may play an important role in the modulation of the inflammatory process and the immune response.
EXPERIMENTAL

Cell culture and reagents
The mouse macrophage cell line RAW 264.7 (A.T.C.C., Rockville, MD, U.S.A.) was cultured in RPMI 1640 medium (Invitrogen) supplemented with 5 % fetal calf serum (Lonza), 100 units/ml penicillin, 100 μg/ml streptomycin, 1000 units/ml gentamycin, 2 mM L-glutamine and 0.1 mM non-essential amino acids. Cells were treated with LPS from Escherichia coli serotype 026:B6 (Sigma-Aldrich) at 1 μg/ml. The selective COX-2 inhibitors Celecoxib and NS398 (Alexis Biochemicals) were used at final concentrations between 0.01 and 1 μM. The PGE 2 , EP2 and EP4 agonists CAY10399 and PGE 1 OH, and the EP2 antagonist AH6809, were purchased from Cayman Chemical. dbcAMP (dibutyryl-cAMP; 100 μM) and forskolin (10 μM) were from Sigma. NSAIDs and PKA inhibitors H89 (10 μM) and KT5720 (1 μM) (Enzo Life Sciences) were added 1 h before cell stimulation with PGE 2 or LPS.
Plasmid constructs
The COX2 promoter-luciferase construct PGHS-2 Medium ( − 1844) (PGHS is PGH endoperoxide synthase) was provided by Dr Stephanie Vogel (University of Maryland Medical Center, Baltimore, MD, U.S.A.) [24] . PGHS-2-400 and PGHS-2-250 constructs were kindly provided by Dr Harvey Herschman (Molecular and Medical Pharmacology, University of California at Los Angeles, Los Angeles, CA, U.S.A.) [25] ; PGHS-2-150, PGHS-2-88 and CRE-mutated PGHS-2-400 and PGHS-2-88 constructs were generated by Dr Virginia Vila-del Sol (Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Madrid, Spain) [26] . Luciferase constructs containing different deletions of the murine promoter of mPGES-1 (mPGES-1-895, mPGES-1-694, mPGES-1-483 and mPGES-1-154) were as described previously [13] . The CRE-LUC (luciferase) plasmid contained four copies of the CRE site of the human choriogonadotropin gene promoter ( − 147 to − 129) [27] . An EP2 expression vector (pcDNA 3.1-EP2) was obtained from Missouri S&T UMR cDNA Resource Center. The expression vector for the catalytic subunit of PKA was as described previously [28] . Total RNA was obtained from cells using the TRIzol ® reagent RNA isolation protocol (Invitrogen). For standard RT (reverse transcription)-PCR, RNA (1 μg) was reverse-transcribed by the RNA PCR core kit (PerkinElmer). cDNA was used for PCR amplification to analyse EP expression by standard RT-PCR using specific primers: EP1, sense 5 -TTAACCTGAGCCTAG-CGGATG-3 and antisense 5 -CGCTGAGCGTATTGCACACTA-3 ; EP2, sense 5 -CCACGATGCTCTCCTGCTGCTTAT-3 and antisense 5 -CAGCCCCTTACACTTCTCCAATGA-3 ; EP3, sense 5 -TGACCTTTGCCTGCAACCTG-3 and antisense 5 -G-ACCCAGGGAAACAGGTACT-3 ; EP4, sense 5 -CTTACTC-ATCGCCACCTCTCTGGT-3 and antisense 5 -TGTGGCTCC-CACTAACCTCATCCAC-3 ; and β-actin, sense 5 -CTCTTTG-ATGTCACGCACGATTTC-3 and antisense 5 -GTGGGCCG-CTCTAGGCACCAA-3 . Template was amplified by [25] [26] [27] [28] [29] [30] cycles of denaturation at 94
• C for 45 s, annealing at 55 or 60
• C for 45 s, and extension at 72
• C for 45 s. PCR products were separated by agarose gel electrophoresis and visualized by ethidium bromide staining. Results shown correspond to a number of cycles at which the amount of amplified product is proportional to the abundance of starting material.
For quantitative real-time RT-PCR analysis, total RNA was reverse-transcribed using the components of the High-Capacity cDNA Archive Kit (Applied Biosystems). Amplification of the COX2 and mPGES-1 cDNAs was performed using the TaqMan Universal PCR Master Mix (Applied Biosystems) on an ABI PRISM 7900HT instrument (Applied Biosystems) for 40 cycles with specific primers and TaqMan MGB (minor groove binder) probes for COX1, COX2, mPGES-1, EP1, EP2, EP3, EP4 and 18S rRNA (Applied Biosystems). All samples were run in triplicate. Quantification of gene expression by real-time RT-PCR was calculated by the C T (comparative threshold cycle) method, following the manufacturer's instructions. RQ (relative quantification) of mRNA levels was determined using endogenous expression of 18S rRNA and is shown in all of the experiments as RQ + − S.D.
Western blotting
Protein extracts were obtained as described previously [13] . Protein concentration was determined by the BCA method (Thermo Scientific). Cell lysates were subjected to Western blot analysis using conventional SDS/PAGE and protein transfer to nitrocellulose filters. Membranes were incubated with the indicated antibodies and developed by the ECL (enhanced chemiluminescence) system (Thermo Scientific). COX-2 and mPGES-1 protein expression was detected using a monoclonal anti-COX-2 antibody (BD Transduction Laboratories) and a polyclonal rabbit anti-mPGES-1 antibody (Cayman Chemical). Antibodies against CREB and pCREB were purchased from .7 cells were treated with LPS (1 μg/ml) for 24 h in the presence or absence of increasing doses (1-100 nM) of the COX-2 inhibitors NS398 or Celecoxib (Celec). PGE 2 production in cell supernatants of RAW 264.7 cells was determined by a standard EIA assay as described in the Experimental section. Analysis of COX2 (C and D) and mPGES-1 (E and F) mRNA levels by real-time quantitative RT-PCR in RAW 264.7 cells treated with LPS for 24 h along with increasing doses (1-100 nM) of Celecoxib (C and E) or NS398 (D and F) in the presence or absence of PGE 2 (5 μM) as indicated. COX2 and mPGES-1 mRNA levels were normalized to the expression of 18S rRNA and are shown as percentage of induction + − S.D., considering the induction obtained upon LPS treatment to be 100 %. *P < 0.05; **P < 0.01. ns, not significant.
Upstate Signalling. The β-actin level was used as a loading control in each lane.
ChIP (chromatin immunoprecipitation) assay
Specific binding of CREB and pCREB to COX2 and mPGES-1 promoters was determined by ChIP assays as described previously [13] . Briefly, RAW 264.7 cells treated with PGE 2 (5 μM) at the indicated times were fixed with 1 % formaldehyde and lysed in ice-cold lysis buffer [10 mM Hepes, pH 7.6, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT (dithiothreitol) and 0.1 % NP-40 (Nonidet P40) with protease inhibitors]. The pellet of nuclei was suspended in nuclear lysis buffer (50 mM Tris/HCl, pH 8, 10 mM EDTA, 1 % SDS and protease inhibitors) and then chromatin DNA was sheared by sonication. Lysates were pre-cleared with salmon sperm/Protein A-agarose. A sample of input DNA was collected. Protein-DNA complexes were immunoprecipitated overnight at 4
• C with anti-CREB or antipCREB polyclonal antibodies or non-immune rabbit antiserum as a control. Antibody-protein-DNA complexes were incubated with salmon sperm DNA/Protein A-agarose for 30 min followed by washes with wash buffer (20 mM Tris/HCl, pH 8, 2 mM EDTA, 0.1 % SDS, 1 % NP-40 and 500 mM NaCl) and TE buffer (20 mM Tris/HCl, pH 8.0, and 2 mM EDTA). Protein-DNA complexes were eluted and disrupted by incubating at 65
• C followed by proteinase K treatment. DNA was extracted with a QIAquick PCR Purification kit (Qiagen). PCR was conducted using promoterspecific primers for COX2 and mPGES-1, and amplified bands were analysed by 2 % agarose gel electrophoresis.
PGE 2 determination
After various treatments, PGE 2 levels were measured in culture supernatants of RAW 264.7 cells using a competitive immunoassay PGE 2 EIA (enzyme immunoassay) kit, following the manufacturer's instructions (Cayman Chemical).
Statistics
Results are expressed as means + − S.D. from at least three independent experiments performed in duplicate or triplicate. Data were analysed by ANOVA followed by Tukey's test and by Student's paired t test to compare different assay groups using OriginPro 7.5 software. P < 0.05 was considered statistically significant.
RESULTS
Effect of the inhibition of PGE 2 production on LPS-mediated induction of COX-2 and mPGES-1 expression
Expression of the enzymes COX-1, COX-2 and mPGES-1 involved in PGE 2 biosynthesis was assessed by quantitative real-time RT-PCR in the murine macrophage cell line RAW 264.7 after LPS treatment ( Figure 1A ). Low levels of expression of COX-1 (average C T = 33.11), COX-2 (average C T = 29.28) and mPGES-1 (average C T = 32.15) were observed in these cells in basal conditions. Upon LPS treatment for 24 h, COX2 and mPGES-1 mRNA levels were up-regulated 20-and 5-fold respectively, whereas COX1 expression was reduced by 2-fold, thus pointing to COX-2 and mPGES-1 as the main enzymes involved in enhanced PGE 2 production in LPS-treated RAW 264.7 cells. Accordingly, treatment with increasing doses (1-100 nM) of the COX-2 inhibitors Celecoxib or NS398 led to a decrease in the production of PGE 2 induced by LPS ( Figure 1B) .
In order to study the effect of COX-2 inhibitors on the expression of COX-2 and mPGES-1, mRNA levels were determined by quantitative real-time RT-PCR in RAW 264.7 cells treated with LPS for 24 h in the presence of increasing doses of NS398 or Celecoxib. As shown in Figures 1(C)-1(F) , LPS-mediated increase in COX-2 and mPGES-1 expression was attenuated by increasing doses of NS398 and Celecoxib (1-100 nM), suggesting that suppression of endogenous PGE 2 may cause a reduction in LPS-induced expression of mPGES-1 and COX2 mRNA. Moreover, attenuation of mPGES-1 and COX-2 expression by NSAIDs was effectively restored by exogenous PGE 2 ( Figures 1C-1F ).
Induction of COX-2 and mPGES-1 expression by PGE 2
In order to analyse the effect of PGE 2 on COX-2 and mPGES-1 expression, we treated murine RAW 264.7 macrophages with increasing doses of PGE 2 (0.1-10 μM) for 24 h. Quantitative RT-PCR and Western blots showed that COX-2 and mPGES-1 expression was significantly enhanced in a dose-dependent manner by PGE 2 (Figures 2A and 2B ). PGE 2 treatment led to an early induction of COX2 mRNA, whereas mPGES-1 mRNA reached peak levels at 24 h after stimulation ( Figure 2C ).
Furthermore, PGE 2 co-operated with LPS in the induction of COX2 and mPGES-1 mRNA levels ( Figure 2D ).
EP2 participates in PGE 2 -dependent transcriptional induction of COX-2 and mPGES-1
Four different EP receptors mediate PGE 2 -dependent intracellular signalling [14] [15] [16] . In basal conditions, murine macrophage cell lines cells express mainly EP2 and EP4 receptors [29] [30] [31] . Analysis of mRNA levels for the EP receptors in control RAW 264.7 cells confirmed the presence of EP2 and EP4 transcripts with very low levels of EP1 and EP3 transcripts ( Figure 3A , left-hand panel increased in a time-dependent manner. On the other hand, both PGE 2 and LPS treatment promoted a decrease in EP4 mRNA levels ( Figure 3A) .
Treatment of RAW 264.7 cells with the EP2 agonist CAY10399 or with the EP4 agonist PGE 1 OH revealed that EP2 triggering participates in the induction of both COX2 and mPGES-1 mRNA levels ( Figure 3B ). Involvement of EP2 signalling in the induction of the expression of these enzymes was confirmed with the use of the EP2 antagonist AH6809, which was able to reverse PGE 2 -mediated effects ( Figure 3C) .
Moreover, luciferase assays using COX-2 and mPGES-1 mouse promoter constructs (PGHS-2 Medium and mPGES-1-895) showed that transient expression of EP2 receptor mediated transcriptional activation of COX-2 and mPGES-1 after PGE 2 stimulation of RAW 264.7 cells (Figure 3D ).
dbcAMP increases COX-2 and mPGES-1 expression
PGE 2 signalling through the EP2 receptor promoted an increase in intracellular levels of cAMP due to activation of adenylate cyclase [15] . Incubation of RAW 264.7 cells with the cell-permeant cAMP analogue dbcAMP induced an early accumulation of COX2 mRNA at 3 and 8 h, whereas a significant increase in mPGES-1 mRNA levels was detected after 24 h of treatment ( Figure 4A ). Analysis of protein levels by Western blotting showed an increase in COX-2 and mPGES-1 protein levels after dbcAMP treatment, with maximal induction at 24 h ( Figure 4B) . A co-ordinated increase in COX-2 and mPGES-1 expression after dbcAMP stimulation led to enhanced production of PGE 2 by these cells ( Figure 4C ).
dbcAMP co-operates with LPS in the induction of COX-2 and mPGES-1
Combined treatment of RAW 264.7 cells with LPS and dbcAMP strongly enhanced transcription of COX2 and mPGES-1 genes. Induction of COX2 and mPGES mRNA levels in for three experiments. Paired Student's t tests indicate a significant difference between stimulated and H89-or KT5720-treated groups (***P < 0.005; **P < 0.01; *P < 0.05).
these cells by LPS was enhanced in the presence of dbcAMP ( Figure 5A ), resulting in augmented PGE 2 production by these cells ( Figure 5B ). The effect of dbcAMP on LPS-mediated transcriptional activation was also analysed on COX2 and mPGES-1 promoter activity. As shown in Figure 5 (C), LPS and dbcAMP co-operated in the induction of the transcriptional activity of both promoters compared with the induction after stimulation with either dbcAMP or LPS.
PKA regulates COX-2 and mPGES-1 expression by PGE 2
Signalling through the cAMP pathway leads to the activation of PKA, which in turn may activate cAMP-dependent gene transcription [32, 33] . We next analysed the involvement of this signalling pathway in the activation of COX-2 and mPGES-1 expression in RAW 264.7 macrophages. As shown in Figure 6 (A), inhibition of PKA by H89 produced a decrease in the induction of COX-2 and mPGES-1 promoted by PGE 2 treatment or by activation of adenylate cyclase by forskolin. PKA inhibition was also able to abolish EP2-mediated induction of COX2 and mPGES-1 promoter activity after PGE 2 treatment ( Figure 6B ). Interestingly, overexpression of an expression vector for the catalytic subunit of PKA significantly increased activity of the COX2 and mPGES-1 promoters and co-operated with LPS to further induce transcriptional activation of these promoters ( Figure 6C ). Moreover, inhibition of PKA by either H89 or KT5720 promoted a substantial reduction in LPS + dbcAMP induction of PGE2 production by RAW 264.7 cells (Figure 6D ). 
PGE 2 induces CRE-mediated COX-2 and mPGES-1 expression
Since CREB is the main transcriptional mediator of the cAMP/PKA signal [32, 33] , we evaluated the effect of PGE 2 on CREB phosphorylation and CRE-mediated transcriptional activation. Incubation of RAW 264.7 cells with PGE 2 led to efficient CREB phosphorylation ( Figure 7A ). Furthermore, PGE 2 as well as forskolin and dbcAMP activated CRE-dependent gene transcription of a luciferase reporter construct ( Figure 7B ). CREdependent transcription upon PGE 2 stimulation was enhanced in cells co-transfected with an EP2 expression vector ( Figure 7C ).
Previous studies have described a functional CRE-binding site in the murine COX2 promoter [34] . We have analysed the functional significance of this CRE-binding site in PGE 2 -dependent COX-2 transcriptional activity by using different deletions of the COX2 promoter in cells co-transfected with the EP2 receptor. Mutation of the sequence containing the CRE site within the COX2 gene abolished the induction of COX2 promoter activity by PGE 2 in RAW 264.7 cells ( Figure 8A ). Analysis of the activity of different deletions of the murine mPGES-1 promoter (mPGES-1-895, mPGES-1-694, mPGES-1-483 and mPGES-1-154) showed that deletion of the region located at position − 483/ − 154 of the mPGES-1 transcription start site resulted in a clear reduction of the inducibility by PGE 2 ( Figure 8C ). Sequence analysis of this region in the mPGES-1 murine gene to identify potential CRE elements with the TRANSFAC Database and P-Match software [35] revealed the presence of two putative CRE elements (5 -tcagTGATAtgc-3 and 5 -gtccTGAGCcaa-3 ) located at positions − 301/ − 290 and − 217/ − 206 of the mPGES-1 transcription start site, with a high score of core similarity (0.976 and 0.988) and matrix similarity (0.916 and 0.894). The upper case letters indicate the positions in the sequence that match with the core sequence of the matrix, whereas the lower case letters refer to the remaining positions of the matrix.
To confirm the involvement of CREB in the induction of COX-2 and mPGES-1 by PGE 2 , we examined CREB binding to mouse COX2 and mPGES-1 promoters by ChIP assays in PGE 2 -treated RAW 264.7 cells. As shown in Figures 8(B) and 8(D) , PGE 2 stimulation resulted in increased binding of CREB to both COX2 and mPGES-1 promoters.
DISCUSSION
PGE 2 plays an important role in the modulation of the inflammatory and immune response through autocrine and paracrine signalling participating in the regulation of cytokine production, leucocyte migration, proliferation and differentiation [36] [37] [38] . Activation of specific EP receptors by this PG has been shown to regulate the function of many cell types including macrophages, dendritic cells and T-and B-lymphocytes, leading to both pro-and anti-inflammatory effects. Emerging results reveal that regulatory effects of PGE 2 in inflammation depend on receptor subtype, cell population and context of activation. Although mostly implicated as a pro-inflammatory agent, PGE 2 is also able to down-regulate the expression of inflammatory cytokines and chemokines from activated macrophages and dendritic cells [18] [19] [20] [21] 39, 40] . Macrophages are the main source of PGE 2 generated in settings of inflammation upon activation by a stimulus such as LPS, TNFα or IL-1β. Enhanced release of PGE 2 in response to these stimuli is due to co-ordinated up-regulation of COX-2 and mPGES-1 [41, 42] . The molecular mechanisms that regulate PGE 2 synthesis by macrophages involve transcriptional and post-transcriptional processes, with NF-κB, CREB/AP-1 (activator protein 1) and C/EBP (CCAAT/enhancerbinding protein) transcription factors as critical modulators of COX2 gene transcription [23, 26, 34, 43] . On the other hand, induced expression of mPGES-1 depends essentially on the transcription factor EGR-1, although other factors such as NF-κB and Sp1 (specificity protein 1) have also been shown to participate in its regulation [13, 41, [44] [45] [46] . In the present study, we provide evidence that PGE 2 is able to enhance transcriptional activation of COX2 and mPGES-1 in the LPS-activated RAW 264.7 murine macrophage cell line. This PGE 2 -mediated positive loop involves the activation of the EP2/cAMP/PKA signalling pathway, resulting in CREB-dependent transcriptional activation of COX2 and mPGES.
LPS treatment of RAW 264.7 cells induces the synthesis of COX-2 and mPGES-1, which is accompanied by a significant increase in the release of PGE 2 . The results of the present study show that COX-2-selective inhibitors down-regulate the expression of these enzymes at a concentration dose that abrogated LPS-mediated PGE 2 production in RAW 264.7 cells, suggesting a positive regulation of this PG on the expression of COX-2 and mPGES-1. In fact, exogenous PGE 2 treatment reversed the effect of COX-2 inhibitors in LPS-stimulated RAW.264.7 cells. Moreover, PGE 2 treatment in unstimulated RAW 264.7 cells was able to induce COX2 and mPGES-1 transcriptional induction. The ability of PGE 2 to promote COX-2 and mPGES-1 expression in unstimulated cells was weak compared with LPS, but PGE 2 was able to enhance LPS-mediated up-regulation of both enzymes. Induction of COX-2 and mPGES-1 showed different kinetics, with a delay in mPGES-1 induction in comparison with COX-2. Although COX-2 and mPGES expression vary similarly in response to a variety of stimuli (IL-1β, LPS, TNFα etc.), there are multiple reports showing differences in the specific timing for induction, in such a way that induction of mPGES-1 is generally delayed with respect to COX-2 in several cell systems [10] [11] [12] [13] . These observations suggest a differential regulation of these enzymes in terms of the up-regulation and maintenance of steady-state expression levels. Some differences between these two genes that could be relevant to explain divergences in the timing of responses to the same stimuli have been reported. The promoter of human mPGES-1 lacks a TATA box, unlike the COX2 promoter. Furthermore, mPGES-1 mRNA does not contain AUUUA instability motifs that are present in COX2 mRNA [44] . The delayed induction of mPGES mRNA compared with COX2 upon a stimulatory treatment can thus be explained on the basis of a smaller increase in the rate of gene transcription in the setting of a relatively stable mRNA. PGE 2 exerts its effects through a family of G-protein-coupled receptors named EP-1, -2, -3 and -4 that differ in their signal transduction pathways. EP2 and EP4 receptors are coupled to the G s protein and activate adenylate cyclase, increasing cAMP levels [14] [15] [16] . In agreement with previous reports analysing the expression of EP receptors in murine macrophages, we have detected the expression of EP2 and EP4 receptors in RAW 264.7 cells, with negligible levels of EP1 and EP3 receptors [29, 30, [47] [48] [49] . Our results show that expression levels of EP2 and EP4 receptors change inversely in such a manner that basal low levels of EP2 receptor are increased in a time-dependent manner upon LPS treatment, whereas EP4 expression diminished in stimulated RAW 264.7 cells. Moreover, a similar profile on the regulation of EP2 and EP4 mRNA levels was observed upon PGE 2 treatment. Differential regulation of EP2 and EP4 receptors upon activation or PGE 2 treatment involving cAMP signalling have been observed in murine macrophages [30, [47] [48] [49] . In the present study, we provide evidence indicating the involvement of EP2 receptor in the PGE 2 positive loop by the use of EP2 receptor agonists and antagonists as well as overexpression of this receptor in RAW 264.7 cells. EP2 receptor couples to G αs , leading to the activation of adenylate cyclase and increased formation of intracellular cAMP and thus activation of the cAMP-dependent protein kinase PKA. In the present study, we show that treatment of unstimulated RAW 264.7 cells with cAMP analogues or adenylate cyclase activators induced COX-2 and mPGES-1 expression, resulting in augmented PGE 2 production. These agents co-operated with LPS to further upregulate COX-2 and mPGES-1 expression and PGE 2 production by RAW 264.7 cells. Involvement of PKA was revealed by the use of the PKA inhibitors H89 and KT5720, which down-regulated cAMP-dependent transcriptional up-regulation of COX-2 and mPGES-1. Furthermore, overexpression of a catalytic active PKA was able to induce the activity of COX2 and mPGES-1 promoters, both in basal and LPS-stimulated RAW 264.7 cells. Activation of PKA by cAMP can result in the phosphorylation of CREB, which interacts with CREs, resulting in the regulation of cAMPresponsive gene expression [32, 33] . The present study shows that PGE 2 treatment of RAW 264.7 cells induced phosphorylation of CREB at Ser 133 , resulting in the transcriptional activation of a CRE-luciferase reporter. Induction of CREB-mediated transcriptional activation of this reporter construct could be observed in the presence of overexpressed EP2 receptor. CREB-dependent regulation of COX2 promoter activity in response to a variety of stimuli has been observed in different cell types [34, [50] [51] [52] . Our ChIP assays showed that PGE 2 treatment led to CREB binding to the murine COX2 promoter, but also to the mPGES-1 promoter, involving for the first time this transcription factor in the regulation of this gene in response to cAMP-elevating agents. Moreover, analysis of the regulation of COX2 as well as mPGES-1 promoter activity by PGE 2 in RAW 264.7 cells not only confirmed the role of the CRE sequence in the COX2 promoter, but also localized a PGE 2 -responsive region ( − 483 to − 154) within the murine mPGES-1 promoter containing two putative CRE elements.
In summary, the results of the present study point to an essential role of the EP2 receptor in PGE 2 -mediated regulation of COX-2 and mPGES-1 expression though the cAMP/PKA/CREB signalling pathway in RAW 264.7 cells. An autocrine PGE 2 positive feedback involving both EP2 as well as EP4 receptors has been suggested previously as a mechanism modulating COX-2 induction and PGE 2 production [51] [52] [53] [54] . The results of the present study cannot entirely discard the involvement of EP4 receptormediated signalling in these effects. EP2 and EP4 receptors apparently act redundantly in some processes, although they show important functional differences that may explain their distinct roles in others [14, 15] . Even though these receptors share common signal transduction pathways through the activation of adenylate cyclase, they differ in their desensitization and internalization [55, 56] as well as in the signalling properties [15, 57] . G s -mediated increases in cAMP seem to play a less important role for EP4 receptor signalling compared with the EP2 receptor in such a way that inhibition of PKA by H89 is able to attenuate PGE 2 -mediated phosphorylation of CREB in EP2-expressing cells, but not in EP4-expressing cells [57] . Furthermore, the existence of a functional switch from EP4 to EP2 upon macrophage treatment with LPS or with cAMP-elevating agents, in such a way that the EP4 receptor is down-regulated whereas EP2 expression levels are increased, points to EP2 as the predominant isoform in activated macrophages (the present study and [47, 49] ).
In summary, the present study demonstrates the existence of a positive-feedback regulation of PGE 2 -synthesizing enzymes, such as COX-2, but also mPGES-1, in macrophages, which may play an important role in the actions of this PG in the modulation of the inflammatory process and the immune response.
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